• dr-v
    Meet the Team

    Jacob Vanlandingham, Ph.D.

    Dr. VanLandingham is currently an Assistant Professor for the Florida State University Department of Biomedical Sciences.

    Read More »

  • michael-l
    Meet the Team

    Michael Lewandowski

    Mr. Lewandowski is an entrepreneur with over 37 years of pharmaceutical development experience working with pharmaceutical companies and clinical research organizations in developing small and large molecule drugs.

    Read More »

  • megan
    Meet the Team

    Megan Munyon

    Miss Deane brings over ten years’ experience in the hospitality industry, as well as management skills from a variety of business operations.

    Read More »

  • marc
    Meet the Team

    Marc Cantillon

    Dr. Cantillon is a pharmaceutical physician executive with over 16 years of broad experience across multiple critical functions.

    Read More »

  • deepa
    Meet the Team

    Deepa Deshpande

    Dr. Deshpande is providing guidance for the Regulatory pathway to get a drug approved by the FDA.

    Read More »

  • daniel
    Meet the Team

    Daniel Levy

    Dr. Levy’s role is to manage the synthetic process development of PRV-001 with the goal to optimize the process for yield and manufacturing cost.

    Read More »

  • scott
    Meet the Team

    Scott M. Wheelwright, Ph.D.

    Dr. Wheelwright is our lead consultant for CMC, including manufacturing and quality assurance.

    Read More »

Recent News
  • Brett Favre, Concussion Victim, Is Backing Research into a Concussion Drug

    By JENNY VRENTAS November 07, 2017 On the last play of Brett Favre’s football career, he suffered a concussion. In the seven years since his retirement, the Hall of Fame quarterback has become increasingly honest regarding his concerns about the long-term consequences of the sport through which he made his name. There are times Favre will run into […]

    Read More »

  • A Local Solution for Concussion ‘Epidemic’: Prevacus Could be a Football Sideline Staple

    The Prevacus story starts in Tallahassee, specifically at Florida High and Florida State University. Where the story ends is uncertain because nobody has all the answers concerning the long-term effects of concussions. However, the potentially groundbreaking drug could help change that. Prevacus is being developed by Jake VanLandingham, a neuroscientist and a former member of […]

    Read More »

  • Can this Drug Save Football?

    Brett Favre had a 20-year career in the NFL, including an iron-man stint in which he played in 321 straight games. But it was his last play in the league that was a painful exclamation point on his illustrious tenure. In December 2010, while playing for the Vikings, the quarterback was sacked and knocked out […]

    Read More »

  • Prevacus Announces the Addition of Key Individuals to its Sports Advisory Board

    TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced the addition of Steve Mariucci, Eddie DeBartolo Jr., Matt Hasselbeck and Warren Moon to its sports advisory board. “I am delighted to have the […]

    Read More »

  • Prevacus Announces Appearance on Fox Business

    TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced that Dr. Jake VanLandingham and investor Brett Favre appeared on Fox Business’ “Mornings with Maria” on Friday, February 10, 2017 to discuss the Company’s […]

    Read More »

Concussion Facts

The number one cause of concussions in general is wheel sports, such as cycling.

Load New Fact